A 3-Case Series of Autoimmune Haemolytic Anaemia and COVID-19 : Is Plasma Exchange an Alternative?

© The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021..

COVID-19 has rarely been associated with immune-mediated phenomena such as autoimmune haemolytic anaemia (AIHA). Both cold hemolysis with cold agglutinin detection and warm haemolysis have been described with variable prognoses. Current treatment regimens are based on experience with other case series and case reports, which still represent a clinical challenge. Corticosteroids, red cell transfusions and rituximab have been successfully employed. We present 3 cases of AIHA in the context of COVID-19 disease, the first case successfully treated with plasma exchange and long-term follow-up of the 3 cases showing complete remission of anaemia.

Media Type:

Electronic Article

Year of Publication:

2021

Contained In:

SN comprehensive clinical medicine - (14.04.2021), p. 1-4

Language:

English

Contributors:

Ramos-Ruperto, L
García-Pérez, Eduardo
Hernández-Maraver, D
Kerguelén-Fuentes, A
Viejo-Llorente, A
Robles-Marhuenda, Á
Busca-Arenzana, C

Links:

Volltext

Keywords:

Autoimmune haemolytic anaemia
COVID-19
Corticosteroids
Journal Article
Plasma exchange

Notes:

Date Revised 21.04.2021

published: Print-Electronic

Citation Status Publisher

Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Physical Description:

Online-Ressource

doi:

10.1007/s42399-021-00884-6

PMID:

33870092

PPN (Catalogue-ID):

NLM325346224